317
Views
2
CrossRef citations to date
0
Altmetric
Retina/Optic Nerve

Global Current Practice Patterns for the Management of Exogenous Endophthalmitis: A Survey by the American Society of Ophthalmic Trauma

, , , , , ORCID Icon, , , , , , ORCID Icon, , , & show all
Pages 802-808 | Received 31 Aug 2021, Accepted 02 Dec 2021, Published online: 13 Jan 2022

References

  • Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, McDonnell PJ. Acute endophthalmitis following cataract surgery: a systematic review of the literature. Arch Ophthalmol. 2005;123(5):613–20. doi:10.1001/archopht.123.5.613.
  • Cao H, Zhang L, Li L, Lo S. Risk factors for acute endophthalmitis following cataract surgery: a systematic review and meta-analysis. Plos One. 2013;8(8):e71731. doi:10.1371/journal.pone.0071731.
  • Peck TJ, Patel SN, Ho AC. Endophthalmitis after cataract surgery: an update on recent advances. Curr Opin Ophthalmol. 2020;32(1):62–68. doi:10.1097/icu.0000000000000727.
  • Oshima Y, Kadonosono K, Yamaji H, Inoue M, Yoshida M, Kimura H, Ohji M, Shiraga F, Hamasaki T, Jmvss G. Multicenter survey with a systematic overview of acute-onset endophthalmitis after transconjunctival microincision vitrectomy surgery. Am J Ophthalmol. 2010;150(5):716–25. doi:10.1016/j.ajo.2010.06.002.
  • Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y. Incidence of endophthalmitis after vitrectomy: a systematic review and meta-analysis. Retina. 2019;39(5):844–52. doi:10.1097/iae.0000000000002055.
  • Govetto A, Virgili G, Menchini F, Lanzetta P, Menchini U. A systematic review of endophthalmitis after microincisional versus 20-Gauge vitrectomy. Ophthalmology. 2013;120(11):2286–91. doi:10.1016/j.ophtha.2013.04.010.
  • Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C. FRCR net (French Retina specialists net). Endophthalmitis after intravitreal injections: incidence, presentation, management, and visual outcome. Am J Ophthalmol. 2015;160(1):17–25. doi:10.1016/j.ajo.2015.04.013.
  • Mccannel CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Retina. 2011;31(4):654–61. doi:10.1097/iae.0b013e31820a67e4.
  • Meredith TA, McCannel CA, Barr C, Doft BH, Peskin E, Maguire MG, Martin DF, Prenner JL, Group C of A-RMDTTR. Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT). Ophthalmology. 2015;122(4):817–21. doi:10.1016/j.ophtha.2014.10.027.
  • Gokce G, Sobaci G, Ozgonul C. Post-traumatic endophthalmitis: a mini-review. Semin Ophthalmol. 2014;30(5–6):470–74. doi:10.3109/08820538.2013.877939.
  • Essex RW, Yi Q, Charles PGP, Allen PJ. Post-traumatic endophthalmitis. Ophthalmology. 2004;111(11):2015–22. doi:10.1016/j.ophtha.2003.09.041.
  • Henry CR, Flynn HW, Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis A 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119(12):2443–49. doi:10.1016/j.ophtha.2012.06.030.
  • Rahmani S, Eliott D. Postoperative Endophthalmitis: a review of risk factors, prophylaxis, incidence, microbiology, treatment, and outcomes. Semin Ophthalmol. 2017;33(1):1–7. doi:10.1080/08820538.2017.1353826.
  • Manning S, Ugahary LC, Lindstedt EW, Wubbels RJ, Dissel JT, Jansen JTG, Gan I, Goor AT, Bennebroek CA, Werf DJ, et al. A prospective multicentre randomized placebo‐controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics. Acta Ophthalmol. 2018;96(4):348–55. doi:10.1111/aos.13610.
  • Dcw H, Agarwal A, Lee CS, Chhablani J, Gupta V, Khatri M, Nirmal J, Pavesio C, Agrawal R. A review of the role of intravitreal corticosteroids as an adjuvant to antibiotics in infectious endophthalmitis. Ocul Immunol Inflamm. 2016;26(3):1–8. doi:10.1080/09273948.2016.1245758.
  • Albrecht E, Richards JC, Pollock T, Cook C, Myers L. Adjunctive use of intravitreal dexamethasone in presumed bacterial endophthalmitis: a randomised trial. Brit J Ophthalmol. 2011;95(10):1385. doi:10.1136/bjo.2010.187963.
  • Liu SM, Way T, Rodrigues M, Steidl SM. Effects of intravitreal corticosteroids in the treatment of bacillus cereus endophthalmitis. Arch Ophthalmol. 2000;118(6):803–06. doi:10.1001/archopht.118.6.803.
  • Results of the endophthalmitis vitrectomy study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113(12):1479–96. doi:10.1001/archopht.1995.01100120009001.
  • Xu D, Nagiel A, Rahimy E, McCannel CA. Practice patterns of endophthalmitis treatment an international survey of retina specialists. Ophthalmol Retina. 2018;2(9):979–80. doi:10.1016/j.oret.2018.04.008.
  • Feng HL, Robbins CB, Fekrat S. A nine-year analysis of practice patterns, microbiologic yield, and clinical outcomes in cases of presumed infectious endophthalmitis. Ophthalmol Retina. 2020;4(6):555–59. doi:10.1016/j.oret.2020.03.009.
  • Soliman MK, Gini G, Kuhn F, Iros M, Parolini B, Ozdek S, Michalewska Z, Bopp S, Adelman RA, Sallam AB, Group EV-RSES. International practice patterns for the management of acute postsurgical and postintravitreal injection endophthalmitis european vitreo-retinal society endophthalmitis study report 1. Ophthalmol Retina. 2019;3(6):461–67. doi:10.1016/j.oret.2019.03.009.
  • Fliney GD, Pecen PE, Cathcart JN, Palestine AG. Trends in treatment strategies for suspected bacterial endophthalmitis. Graefe’s Archive Clin Exp Ophthalmol. 2018;256(4):833–38. doi:10.1007/s00417-018-3910-3.
  • Miller SC, Fliotsos MJ, Justin GA, Yonekawa Y, Chen A, Hoskin AK, Blanch RJ, Cavuoto K, Meeralakshmi P, Low R, et al. The international globe and adnexal trauma epidemiology study (IGATES). Global current practice patterns for the management of open globe injuries. Am J Ophthalmol. Published online 2021. doi:10.1016/j.ajo.2021.08.003.
  • Ho I-V, Fernandez-Sanz G, Levasseur S, Ting E, Liew G, Playfair J, Downie J, Gorbatov M, Hunyor AP, Chang AA. Early pars plana vitrectomy for treatment of acute infective endophthalmitis. Asia-pacific J Ophthalmol. 2019;8(1):3–7. doi:10.22608/APO.2018414.
  • Negretti GS, Chan W, Pavesio C, Muqit MMK. Vitrectomy for endophthalmitis: 5-year study of outcomes and complications. Bmj Open Ophthalmol. 2020;5(1):e000423. doi:10.1136/bmjophth-2019-000423.
  • Dib B, Morris RE, Oltmanns MH, Sapp MR, Glover JP, Kuhn F. Complete and early vitrectomy for endophthalmitis after cataract surgery: an alternative treatment paradigm. Clin Ophthalmol. 2020;14:1945–54. doi:10.2147/opth.s253228.
  • Welch S, Bhikoo R, Wang N, Siemerink MJ, Shew W, Polkinghorne PJ, Niederer RL. Better visual outcome associated with early vitrectomy in the management of endophthalmitis. Br J Ophthalmol. Published online 2021:bjophthalmol-2020-316846. doi:10.1136/bjophthalmol-2020-316846.
  • Kuhn F, Gini G. Ten years after … are findings of the endophthalmitis vitrectomy study still relevant today? Graefe’s Archive Clin Exp Ophthalmol. 2005;243(12):1197–99. doi:10.1007/s00417-005-0082-8.
  • Grzybowski A, Turczynowska M, Kuhn F. The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? Acta Ophthalmol. 2018;96(5):e651–e654. doi:10.1111/aos.13623.
  • Soliman MK, Gini G, Kuhn F, Parolini B, Ozdek S, Adelman RA, Sallam AB, European Vitreo-Retinal Society (EVRS) Endophthalmitis Study Group. Visual outcome of early vitrectomy and intravitreal antibiotics in acute postsurgical and postintravitreal injection endophthalmitis: European vitreo-retinal society endophthalmitis study report two. Retina. 2020;41(2):423–30. doi:10.1097/iae.0000000000002856.
  • Grzybowski A, Turczynowska M, Schwartz SG, Relhan N, Flynn HW. The role of systemic antimicrobials in the treatment of endophthalmitis: a review and an international perspective. Ophthalmol Ther. 2020;9(3):485–98. doi:10.1007/s40123-020-00270-w.
  • Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003;121(3):345–50. doi:10.1001/archopht.121.3.345.
  • Hariprasad SM, Shah GK, Mieler WF, Feiner L, Blinder KJ, Holekamp NM, Gao H, Prince RA. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol. 2006;124(2):178–82. doi:10.1001/archopht.124.2.178.
  • Doft BH. International practice patterns in the management of postprocedure endophthalmitis. Ophthalmol Retina. 2019;3(6):459–60. doi:10.1016/j.oret.2019.03.020.
  • Gan IM, Ugahary LC, van Dissel JT, Feron E, Peperkamp E, Veckeneer M, Mulder PGH, Platenkamp GJ, van Meurs JC. Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefe’s Archive Clin Exp Ophthalmol. 2005;243(12):1200–05. doi:10.1007/s00417-005-0133-1.
  • Barza M, Pavan PR, Doft BH, Wisniewski SR, Wilson LA, Han DP, Kelsey SF. Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol. 1997;115(9):1142–50. doi:10.1001/archopht.1997.01100160312008.
  • AlBloushi AF, Ajamil-Rodanes S, Testi I, Wagland C, Grant-mckenzie N, Pavesio C. Diagnostic value of culture results from aqueous tap versus vitreous tap in cases of bacterial endophthalmitis. Br J Ophthalmol. Published online 2021:bjophthalmol-2021-318916. doi:10.1136/bjophthalmol-2021-318916.
  • Wisniewski SR, Hammer ME, Grizzard WS, Kelsey SF, Everett D, Packo KH, Yarian DL, Doft BH. An investigation of the hospital charges related to the treatment of endophthalmitis in the endophthalmitis vitrectomy study. Ophthalmology. 1997;104(5):739–45. doi:10.1016/s0161-6420(97)30239-5.
  • Fongsre T, Aiempanakit K, Ratanalerdwee T, Leelaprasasne S, Kanok-Kantapong S, Jamulitrat S. Extra charge and extra length of hospital stay attributable to postcataract surgery endophthalmitis. Am J Infect Control. 2004;32(6):374–75. doi:10.1016/j.ajic.2004.01.005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.